Price
No data yet.
Social Signal Score
Analyst Ratings
7 analystsRevenue
$41.57M+452.33%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Daniel L. Reuvers
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 658
- Beta
- 1.17
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -3.38
Financials
Revenue
$41.57M+452.3%Net Income
$-3.44MEBITDA
$-2.72MFree Cash Flow
$-249.0KEPS (diluted)
$-0.04Shares Outstanding (diluted)
71.37M+635987.3%Operating Expenses
$22.72MCash & Debt
$19.43MRevenue by Segment (annual)
$149.16MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $149.16M | $-39.00M | $-0.59 |
| 2024 | $74.89M | $-43.71M | $-1.38 |
| 2023 | $71.35M | $-30.19M | $-1.05 |
| 2022 | $65.21M | $-37.16M | $-1.38 |
| 2021 | $55.31M | $-31.19M | $-1.22 |
| 2020 | $49.24M | $-27.45M | $-1.46 |
| 2019 | $62.66M | $-29.04M | $-1.87 |
| 2018 | $52.78M | $-24.10M | $-2.69 |
| 2017 | $40.43M | $-16.06M | $-1431.28 |
| 2016 | $34.23M | $-11.23M | $-1001.25 |
Valuation
STIMhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70-55.94%Social Signal Score
Mentions (4)
- Newsglobenewswire.com·28d ago·Positive
…oStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System MALVERN, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced the integration of its TrakStar® practice management platform with AdvancedMD, a leading cloud-based electronic health record (EHR), pr…
View source ↗ - Newsseekingalpha.com·55d ago·Positive
Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·55d ago·Neutral
Neuronetics Q2 Earnings Call Highlights Neuronetics NASDAQ: STIM reported second-quarter 2026 revenue growth, a sharply narrower net loss and positive adjusted EBITDA as its Greenbrook clinic business expanded and the company introduced additional commercial purchasing options for its NeuroStar transcranial magnetic stimulation, or TMS, systems.
View source ↗ - Newszacks.com·56d ago·Neutral
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates Neuronetics (STIM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.15 per share a year ago.
View source ↗
Earnings
Tue, Nov 3(in 4 weeks)
Consensus estimate $-0.08 per share
Typical surprise -8.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 11$-0.05 vs $-0.12beat
- Tue, May 5$-0.16 vs $-0.17beat
- Tue, Mar 17$-0.10 vs $-0.12beat
- Tue, Nov 4$-0.13 vs $-0.12miss
- Tue, Aug 5$-0.15 vs $-0.08miss
- Tue, May 6$-0.21 vs $-0.13miss
Estimates and results for STIM via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by STIM officers and directors.
- Bought
- $4.8m
- Sold
- $14.8m
14 trades
28 trades
- Chernett Joreybought
- Chernett Joreysold
- Chernett Joreybought
- Chernett Joreybought
- Chernett Joreybought
- Chernett Joreybought
- Chernett Joreybought
- Chernett Joreybought
58 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in STIM.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.